1. Home
  2. ALXO vs INTG Comparison

ALXO vs INTG Comparison

Compare ALXO & INTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALXO
  • INTG
  • Stock Information
  • Founded
  • ALXO 2015
  • INTG 1965
  • Country
  • ALXO United States
  • INTG United States
  • Employees
  • ALXO N/A
  • INTG N/A
  • Industry
  • ALXO Biotechnology: Pharmaceutical Preparations
  • INTG Building operators
  • Sector
  • ALXO Health Care
  • INTG Real Estate
  • Exchange
  • ALXO Nasdaq
  • INTG Nasdaq
  • Market Cap
  • ALXO 24.0M
  • INTG 28.9M
  • IPO Year
  • ALXO 2020
  • INTG N/A
  • Fundamental
  • Price
  • ALXO $0.56
  • INTG $12.01
  • Analyst Decision
  • ALXO Strong Buy
  • INTG
  • Analyst Count
  • ALXO 6
  • INTG 0
  • Target Price
  • ALXO $3.30
  • INTG N/A
  • AVG Volume (30 Days)
  • ALXO 456.6K
  • INTG 1.3K
  • Earning Date
  • ALXO 05-08-2025
  • INTG 05-15-2025
  • Dividend Yield
  • ALXO N/A
  • INTG N/A
  • EPS Growth
  • ALXO N/A
  • INTG N/A
  • EPS
  • ALXO N/A
  • INTG N/A
  • Revenue
  • ALXO N/A
  • INTG $61,597,000.00
  • Revenue This Year
  • ALXO N/A
  • INTG N/A
  • Revenue Next Year
  • ALXO N/A
  • INTG N/A
  • P/E Ratio
  • ALXO N/A
  • INTG N/A
  • Revenue Growth
  • ALXO N/A
  • INTG 6.76
  • 52 Week Low
  • ALXO $0.41
  • INTG $10.70
  • 52 Week High
  • ALXO $10.97
  • INTG $22.84
  • Technical
  • Relative Strength Index (RSI)
  • ALXO 59.08
  • INTG 45.59
  • Support Level
  • ALXO $0.44
  • INTG $11.70
  • Resistance Level
  • ALXO $0.48
  • INTG $12.38
  • Average True Range (ATR)
  • ALXO 0.05
  • INTG 0.48
  • MACD
  • ALXO 0.02
  • INTG 0.00
  • Stochastic Oscillator
  • ALXO 99.16
  • INTG 31.46

About ALXO ALX Oncology Holdings Inc.

ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.

About INTG Intergroup Corporation (The)

The Intergroup Corp is an us-based company operating in the real estate sector. It is formed to buy, develop, operate, rehabilitate and dispose of real property of various types and descriptions, and to engage in other related business and investment activities. The company operates through three segments namely Hotel Operations, Real Estate Operations, and Investment Transactions. The Hotel Operations segment which generates the majority of the revenue covers the operation of the Hilton hotel and garage. The Real Estate Operations segment consists of the operation of multifamily rental properties whereas the Investment Transactions segment includes an investment of cash in marketable securities and other investments.

Share on Social Networks: